These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 8081313)

  • 1. Clinical consequences of disorders in the intermediate metabolism of branched chain amino acids (valine, leucine and isoleucine).
    Mogoş T; Cheţa CP; Mincu IT
    Rom J Intern Med; 1994; 32(1):57-61. PubMed ID: 8081313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Disorders of leucine, isoleucine and valine metabolism (maple syrup urine disease)].
    Vulović D; Vilhar N; Hajduković R; Marjanović B; Stojanović Lj
    Srp Arh Celok Lek; 1975 May; 103(5):419-36. PubMed ID: 1188483
    [No Abstract]   [Full Text] [Related]  

  • 3. The relationship between aminoaciduria and plasma hemoglobin levels.
    Mogoş T; Popescu C; Dumitrescu A; Tănase I; Mincu I
    Rom J Intern Med; 1993; 31(3):223-8. PubMed ID: 8130761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Compliance of the diet restricted with leucine, isoleucine and valine in maple syrup urine disease (MSUD) children].
    Kowalik A; Narojek L; Sykut-Cegielska J
    Rocz Panstw Zakl Hig; 2007; 58(1):95-101. PubMed ID: 17711097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma amino acid analyses in two cases of maple syrup urine disease.
    Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on "branched chain oxoacid aciduria" (maple syrup diseases)].
    Goedde HW; Blume KG; Möhlenbeck F; Rotthauwe HW; Simon HA; Lang K
    Med Klin; 1966 Dec; 61(52):2063-7. PubMed ID: 4385693
    [No Abstract]   [Full Text] [Related]  

  • 7. American Academy of Pediatrics. Committee on Nutrition: special diets for infants with inborn errors of amino acid metabolism.
    Pediatrics; 1976 May; 57(5):783-92. PubMed ID: 940719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of branched-chain amino acid intake in children with maple syrup urine disease and methylmalonic aciduria.
    Parsons HG; Carter RJ; Unrath M; Snyder FF
    J Inherit Metab Dis; 1990; 13(2):125-36. PubMed ID: 2116544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leucine equivalency system in managing branched chain ketoaciduria.
    Smith BA; Waisman HA
    J Am Diet Assoc; 1971 Oct; 59(4):342-6. PubMed ID: 5095277
    [No Abstract]   [Full Text] [Related]  

  • 10. [3 patients with maple syrup urine disease].
    Merinero B; del Valle JA; García MJ; García Miguel MJ; Barrio MI; García Hortelano J; Morales E; González F; García Aparicio J; Sáez Pérez E
    An Esp Pediatr; 1983 Nov; 19(5):393-400. PubMed ID: 6660657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical pathology of amino acid diseases.
    Carson NA
    Acta Neurol Psychiatr Belg; 1968 Apr; 68(4):231-44. PubMed ID: 4972604
    [No Abstract]   [Full Text] [Related]  

  • 12. Clearance of branched chain amino acids by peritoneal dialysis in maple syrup urine disease.
    McMahon Y; MacDonnell RC
    Adv Perit Dial; 1990; 6():31-4. PubMed ID: 1982835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dietetics in hereditary enzyme deficiencies].
    Royer P
    Sem Hop; 1970 Feb; 46(10):653-9. PubMed ID: 4314674
    [No Abstract]   [Full Text] [Related]  

  • 14. Experiments of nature involving branch-chain amino acids.
    Smith GA
    Pediatrics; 1967 Jun; 39(6):811-2. PubMed ID: 6026547
    [No Abstract]   [Full Text] [Related]  

  • 15. The need of essential amino acids in children. An evaluation based on the intake of phenylalanine, tyrosine, leucine, isoleucine, and valine in children with phenylketonuria, tyrosine amino transferase defect, and maple syrup urine disease.
    Kindt E; Halvorsen S
    Am J Clin Nutr; 1980 Feb; 33(2):279-86. PubMed ID: 6101930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical characteristics and analysis of mass spectrometric data in 33 patients with maple syrup urine disease].
    Yang N; Han LS; Ye J; Qiu WJ; Zhang HW; Gao XL; Wang Y; Li XY; Xu H; Gu XF
    Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2839-42. PubMed ID: 23290213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of maple syrup disease. Clinical and electroencephalographic observations with dietetic experiment. Critical review of literature].
    Grossi-Bianchi ML; Gatti R; Marchi AG
    Minerva Pediatr; 1967 Aug; 19(33):1552-65. PubMed ID: 4889027
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings: Neonatal diagnosis of maple syrup urine disease and the influence of exchange blood transfusion.
    Russell A; Statter M; Shina A; Perlman M
    Isr J Med Sci; 1975 Nov; 11(11):1218-9. PubMed ID: 1205813
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolongation of G1 and S phase in C-6 glioma cells treated with maple syrup urine disease metabolits. Morphologic and cell cycle studies.
    Liao CL; Herman MM; Bensch KG
    Lab Invest; 1978 Feb; 38(2):122-33. PubMed ID: 564423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of [1-(14)C] and [2-(14)C] leucine in cultured skin fibroblasts from patients with isovaleric acidemia. Characterization of metabolic defects.
    Tanaka K; Mandell R; Shih VE
    J Clin Invest; 1976 Jul; 58(1):164-72. PubMed ID: 932204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.